PreScription: Comments on the FDA Guidance "Compounded Drug Products That Are Essentially Copies of a Commercially Available Drug Product Under Section 503A of the Federal Food, Drug, and Cosmetic Act: Guidance for Industry"
Author(s): Allen Loyd V Jr
Issue: Mar/Apr 2022 - Volume 26, Number 2
View All Articles in Issue
Page(s): 92
Download in electronic PDF format for $75
Abstract:
Related Keywords: U.S. Food and Drug Administration, FDA, Code of Federal Regulations, FDA Guidance for Industry, Federal Food, Drug, and Cosmetic Act section 503A, drug product, pharmaceutical equivalence, pharmaceutical alternatives, finished dosage form